FALL/WINTER 2025
The UC Davis Health Medical Center campus
In brief

Leadership updates

A sampling of recent major achievements and developments from UC Davis Health and the UC Davis School of Medicine. For more listings and news, please visit our newsroom and follow us on social media.

New UC Davis Health top executive named

Mark I. Rosenblatt, M.D., Ph.D., M.B.A., M.H.A.

UC Davis Chancellor Gary S. May has appointed Mark I. Rosenblatt, M.D., Ph.D., M.B.A., M.H.A., a former UC Davis attending physician and assistant professor, to the position of vice chancellor of human health sciences.

Rosenblatt will oversee UC Davis Health, which includes three hospitals: the nationally ranked UC Davis Medical Center and UC Davis Children’s Hospital, as well as the UC Davis Rehabilitation Hospital. It also includes oversight for two nationally ranked schools of health — the UC Davis School of Medicine and Betty Irene Moore School of Nursing — and a network of primary care clinics across inland Northern California. He will begin Jan. 19, 2026.

“Mark brings to UC Davis deep experience in academic hospital systems. He has made patient care and the patient experience a priority. He has a proven record of collaborating with faculty and staff across medical and other disciplines to leverage the best that a comprehensive university like UC Davis has to offer.”UC Davis Chancellor Gary S. May

Rosenblatt is the G. Stephen Irwin executive dean at the University of Illinois College of Medicine, the chief executive officer of the University of Illinois Hospital and Clinics, and distinguished professor of ophthalmology and visual sciences at the University of Illinois Chicago.

Rosenblatt joined the University of Illinois Chicago in 2014 as professor of ophthalmology. He has held increasing levels of leadership over his decade there, including as head of the Department of Ophthalmology and Visual Sciences at the Illinois Eye and Ear Infirmary, director of the Corneal Regenerative Medicine Laboratory, director of the Medical Scientist Training Program, and graduate faculty in the neuroscience program. Previously, Rosenblatt was a faculty member of the Weill Cornell Medical College for six years, including service as vice chair of the Department of Ophthalmology.

An internationally recognized clinician-scientist, he leads groups of scientists investigating the mechanism of corneal peripheral nerve regeneration following injury, and the use of nanoengineered biomaterials for use in stem cell delivery to the ocular surface. He has published widely, including over 225 original manuscripts, review articles, book chapters and abstracts.

Rosenblatt is a graduate of the University of Miami Miller School of Medicine’s Honors Program in Medical Education and the Combined M.D./ Ph.D. program, receiving his Ph.D. in biochemistry, cell and molecular biology. He completed his M.B.A. at New York University and his M.H.A. at the University of Illinois Chicago School of Public Health. He completed his ophthalmology residency and combined clinical/research fellowship in corneal disease at the Massachusetts Eye and Ear Infirmary/Harvard Medical School.